Lee's Pharm (00950) issued a total of 1,764,000 share purchase rights.
Lee's Big Pharma Company (00950) issues a statement that on October 15, 2025, in accordance with the regulations set forth on May 19, 2022...
LEE'S PHARM (00950) announced that on October 15, 2025, in accordance with the stock option plan adopted on May 19, 2022, it granted stock options (options) to several eligible participants (grantees), which can subscribe for a total of 1.764 million shares of the company's common stock.
Related Articles

New stock news | New Lotus Flower Delivers Table Hong Kong Stock Exchange, company is China's leading supplier of traditional Chinese medicine products, ranked second in the traditional Chinese medicine industry

New Stock News | Minglue Technology-W Attends Hearing in Hong Kong Stock Exchange, Company is China's largest supplier of data intelligence application software.

Shenwan Hongyuan Group: Transitioning from a style of "buying high and selling low" in A shares, but with different offensive and defensive strategies.
New stock news | New Lotus Flower Delivers Table Hong Kong Stock Exchange, company is China's leading supplier of traditional Chinese medicine products, ranked second in the traditional Chinese medicine industry

New Stock News | Minglue Technology-W Attends Hearing in Hong Kong Stock Exchange, Company is China's largest supplier of data intelligence application software.

Shenwan Hongyuan Group: Transitioning from a style of "buying high and selling low" in A shares, but with different offensive and defensive strategies.

RECOMMEND